Recursion Pharmaceuticals logo

Recursion Pharmaceuticals

ID: 5301285

Recursion Pharmaceuticals is a biotechnology and data science company based in Salt Lake City, Utah, founded in 2013, that combines biology with artificial intelligence for drug discovery. Using human cell models of diseases, Recursion captures microscopic images to build biological datasets and computational techniques identify disease-associated.

13

Funding Rounds

$465.4m

Money raised

Overview

Recursion Pharmaceuticals is a biotechnology and data science company based in Salt Lake City, Utah, founded in 2013, that combines biology with artificial intelligence for drug discovery. Using human cell models of diseases, Recursion captures microscopic images to build biological datasets and computational techniques identify disease-associated.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Recursion Pharmaceuticals has raised a total of $45.43m in funding over 13 rounds.

Key Insights:

  • Recursion Pharmaceuticals Venture round, June 5, 2018: $20.5m
  • Recursion Pharmaceuticals Grant (money), May 7, 2018: $546k
  • Recursion Pharmaceuticals Venture round, February 7, 2017: $4m
  • Recursion Pharmaceuticals Series A round, November 2016: $2.15m
  • Recursion Pharmaceuticals Series A round, October 2016: $12.9m
  • Recursion Pharmaceuticals Venture round, December 4, 2015: $2.7m
  • Recursion Pharmaceuticals Grant (money), February 25, 2015: $1.5m
  • Recursion Pharmaceuticals Venture round, February 23, 2015: $830k
  • Recursion Pharmaceuticals Seed round, August 15, 2014: $170k
  • Recursion Pharmaceuticals Seed round, January 1, 2014: $130k
  • Recursion Pharmaceuticals funding round, July 2019: $121m
  • Recursion Pharmaceuticals funding round, October 2017: $60m
  • Recursion Pharmaceuticals Series D round September 2020: $239m